Funding for this research was provided by:
Instituto de Salud Carlos III (PIE15/00068, PI16/00354, PI17/01865)
Comunidad de Madrid (B2017/BMD3733)
Text and Data Mining valid from 2019-05-24
Received: 26 November 2018
Accepted: 6 May 2019
First Online: 24 May 2019
Ethics approval and consent to participate
: Institutional review board approval was obtained from all participating hospitals (the names of the ethics committees were Comité Ético del Hospital La Princesa, Comité Ético del Hospital de Fuenlabrada, Comité Ético Quiron FJD-Pozuelo). All patients provided written informed consent. The study (CNIO-BR-007) was registered at ExternalRef removed (NCT02619162).
: Informed consent form included the permission for trial data publication.
: MQF received research funds from the following companies: Novartis, Roche, Bayer, Boehringer-Ingelheim, Astra Zeneca, and MEI Pharma.
: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.